Chronic Care Management/Patient Relationship Management Proof of Concept
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
This proof of concept study proposes to evaluate the feasibility of a communications-technology-based chronic care and patient relationship management program to improve diabetes self management among adult diabetic patients in an urban safety net population by providing between-visit reminders and chronic disease support through cell phone text messaging.
The investigators hypothesize that diabetic patients enrolled in the program will be less likely to miss scheduled appointments and will have greater perceived self-efficacy and improved patient satisfaction concerning chronic disease management. No-show rates among patients enrolled in the program are expected to be lower than among patients receiving standard care.
Condition | Intervention |
---|---|
Diabetes Mellitus |
Behavioral: Patient Relationship Management (PRM) Program |
Study Type: | Interventional |
Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Health Services Research |
Official Title: | Chronic Care Management/Patient Relationship Management Proof of Concept |
- Technology engagement [ Time Frame: 3 months ] [ Designated as safety issue: No ]Assessment of program feasibility by patient engagement and satisfaction with the technology-based intervention. Measured by analysis of response rates and average response times to medical requests and appointment reminders, and by content analysis of patient survey and focus group data.
- Appointment attendance [ Time Frame: 3 months ] [ Designated as safety issue: No ]As measured by no-show rates for appointments at all clinics during the study period, compared between intervention and control groups
- Perceived self-efficacy [ Time Frame: 3 months ] [ Designated as safety issue: No ]As measured by comparison of patient responses to validated assessment instrument administered at baseline and post-intervention
- Glycemic control [ Time Frame: 3 months ] [ Designated as safety issue: No ]Measured by patients' self-reported fasting blood glucose levels during the intervention period and compared to previous laboratory data in the medical record.
Estimated Enrollment: | 100 |
Study Start Date: | May 2010 |
Estimated Study Completion Date: | November 2010 |
Estimated Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
-
Behavioral: Patient Relationship Management (PRM) Program
- 7 days, 2 days, and 1 day before scheduled appointments. Messages will contain the date, time, and location where the appointment is scheduled. Patients will be prompted to respond with 'YES' if they are able to keep their appointment, and 'NO' if they need to reschedule. An acknowledgement of receipt will be sent in response to all patient-initiated messages.
- 3 days per week to request that patients respond with fasting blood sugar measurements. An acknowledgement of receipt will be sent in response to all patient-initiated messages.
Patients will be contacted through SMS text messaging under the following circumstances:
Ages Eligible for Study: | 18 Years to 76 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients with diabetes
- receive care at a primary care clinic in the DH system
- between 18 and 76 years of age
- primary language of English or Spanish
- ownership of a qualifying cell phone (SMS text capable)
- ownership of a glucometer.
Exclusion Criteria:
- life expectancy less than six months,
- do not have or cannot use a phone or glucometer
- do not want to participate
United States, Colorado | |
Denver Health and Hospital Authority | |
Denver, Colorado, United States, 80204 |
Principal Investigator: | Andrew W Steele, MD, MPH | Denver Health and Hospital Authority |
No publications provided
Responsible Party: | Andrew W. Steele, MD, MPH, MSc, Denver Health and Hospital Authority |
ClinicalTrials.gov Identifier: | NCT01182480 History of Changes |
Other Study ID Numbers: | COMIRB 10-0257 |
Study First Received: | August 11, 2010 |
Last Updated: | August 12, 2010 |
Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on October 17, 2012